Common Contracts
1 similar Asset Purchase Agreement contracts
Asset purchase and settlement agreement for complement inhibition technology including Soliris (eculizumab)Asset Purchase Agreement • February 18th, 2021 • Oklahoma
The Oklahoma Medical Research Foundation and Alexion Pharma has agreed to acquire from OMRF all rights to certain patents related to complement-inhibition technology.
